The purpose of this study is to confirm the superiority of IP in overall survival over EP as post-operative adjuvant chemotherapy for pathological Stage I–IIIA completely resected pulmonary HGNEC patients. Visualizza altro The primary endpoint is overall survival (OS) in all randomized patients. OS is defined as days from randomization to death from any cause, and it is censored at the last day when the patient is alive. The secondary … Visualizza altro After confirming the eligibility criteria, registration is made by telephone, fax or a web-based system to the JCOG Data Center. … Visualizza altro Patients in the EP arm receive four courses of post-operative EP (etoposide, 100 mg/m2/day, Day 1–3; cisplatin 80 mg/m2/day, Day 1) repeated every 3 weeks. Patients … Visualizza altro Webdisease) was found in 4 of 8 (50%) c-N1 cases. JCOG9101 also showed similar results for lymph node metastatic findings, with 5 of 9 (56%) c-N1 cases resulting in p-N2 postoperatively [14]. Video-assisted mediastinoscopy has recently become available and the safety of the procedure has improved. Mediastinoscopy is still a valuable proce-

Irinotecan and cisplatin versus etoposide and cisplatin in small-cell ...

Web30 ott 2024 · Tsuchiya R, Suzuki K, Ichinose Y, Watanabe Y, Yasumitsu T, Ishizuka N, Kato H. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). WebIn the early period, the Lung Cancer Surgical Study Group focused on combined modality therapies and conducted nine trials, including JCOG9101: adjuvant chemotherapy for … crystal check disk

Surgical intervention for small-cell lung cancer: what is

WebBackgrounds: Laparoscopy-assisted distal gastrectomy (LADG) for gastric cancer is safe and feasible. In contrast, no prospective study evaluating the safety and efficacy of … WebTsuchiya R, Suzuki K, Ichinose Y, et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the … WebTsuchiya R, Suzuki K, Ichinose Y, et al. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). crystal check for null